Today, the Smithsonian opened its much-anticipated, three-year exhibit “Outbreak: Epidemics in a Connected World” at the National Museum of Natural Science with support from Johnson & Johnson Innovation, just as another Ebola outbreak is heating up in Democratic Republic of Congo. And earlier this week, we kicked off an exciting new collaboration with the British Science Museum and Royal Society at the Science Meets the Media event and celebrated science journalism at the Association of British Science Writers (ABSW) annual awards.
Science made in Africa – The Next Einstein Forum 2018
The Next Einstein Forum (NEF) is an initiative launched by the African Institute for Mathematical Sciences (AIMS) in 2013, in partnership with Johnson & Johnson Innovation to showcase science in Africa and to give some of the most promising scientists from the African continent a voice. The 2018 meeting took place in Kigali, Rwanda. Attendees included leaders from the fields of science, policy and civil society, and also heads of states such as H.E. President Paul Kagame of Rwanda, and President Macky Sall of Senegal.
Embrace the Opportunity: Announcing the Victorian QuickFire Challenge
On March 27, 2018, the Victorian Government, championed by the Minister for Innovation and the Digital Economy, Philip Dalidakis, announced the launch of the Victorian QuickFire Challenge: Driving Device Innovation in conjunction with the 6th Annual Devices & Diagnostics Lab in Melbourne. This Johnson & Johnson Innovation, JLABS QuickFire Challenge will award a total of AUD 300,000, as well as mentorship from a network of experts, to up to three winners for their game-changing early-stage medical device innovations.
Small Country, big ideas – The "Chutzpah" that is Israeli Innovation
Israeli Innovations have been making the rounds in the last few decades; the Israeli Ecosystem's many inventions and breakthroughs are prized in the country with its well-known moniker – "Start-up Nation".
Reflecting on lively discussions at BIO-Europe Spring, John Isaac shares his thoughts on advances in neuroscience research and the concerted efforts across academia, industry and stakeholders to advance knowledge in this area.
Leading Scientists Take Beauty Beyond the Jar. How Can You Play a Role in Advancing Digital Beauty?
Johnson & Johnson is pushing the boundaries of how consumers experience skincare. At the recent Consumer Electronics Show in Las Vegas, Johnson & Johnson unveiled the Neutrogena Skin360 SkinScanner, a dermatologist-grade skin analysis technology that helps consumers understand, track, and learn how to take care of their skin. The Skin360 SkinScanner helps our consumer accurately measure her skin’s health above and below the surface over time and leverage Neutrogena’s wealth of scientific research to provide the personalized skincare advice she wants.
The Consumer Electronics Show (CES) has just come to an end in Las Vegas, and I was lucky enough to be there again. Since 2002, when CES was still focused on consumer electronics (TV, DVD, audio and some first smart home concepts), I have been visiting CES regularly.
To “skip a stone” takes more than just practice. It requires discriminating selection, as only a tiny subset of stones will do. The perfect stones for this are those that have been polished by time – rounded of rough edges and protected from too much mid-body girth. Slowly acquired features derived from countless collisions along the water’s edge and its constant energy and commotion. Skipping requires momentum, but not just speed. It requires a discrete angular velocity that will enable the first encounter to be rebounded into a series of repeating patterns that allow the stone to touch, taste, re-lift and return across the awaiting surface – again and again. A useful metaphor for many things, but particularly apropos as we gather our things, board our planes, trains or (likely time-shared) automobiles to rejoin as a community at the J.P. Morgan 2018 Healthcare Conference and, our 36th “skip” as an industry. Again, we are all returned to San Francisco to reflect on the trajectory of the biotechnology industry and now healthcare in general. To see how we, as a community, can bring forward new medical advances that are needed all across the world.